Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises DGC in connection with EQT’s acquisition of shares in DGC and subsequent mandatory offer
Mandate

Vinge advises DGC in connection with EQT’s acquisition of shares in DGC and subsequent mandatory offer

June 07, 2017 Capital Markets and Public M&A

Vinge advises DGC One AB (publ) (“DGC”) in connection with EQT’s acquisition of 85.2 percent of the total number of shares and votes in DGC and subsequent mandatory recommended cash offer to the remaining shareholders.

EQT offers SEK 250 in cash per share in DGC. The total offer value for DGC amounts to approximately SEK 2.3 billion.

Vinge’s team consists of Göran Nyström, Dain Hård Nevonen and Sofie Bjärtun. Marcus Glader advices on competition law matters.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025